Profile for Denmark Patent: 2415763

US Patent Family Members and Approved Drugs for Denmark Patent: 2415763

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
	Oct 13, 2029	Ocuvex Therap	OMLONTI	omidenepag isopropyl

Patent DK2415763 Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What is the Scope and Content of DK2415763?

DK2415763, titled "Method of Treating Disease," filed by a pharmaceutical company, covers a therapeutic method involving a specific compound. The patent's scope primarily pertains to the use of this compound in treating particular conditions, with claims focusing on administration protocols and dosage.

The patent aims to secure rights over the treatment method, specifying the chemical entity and its application. It details parameters such as treatment schedules and patient populations, but does not extend to manufacturing or formulation claims.

What are the Key Claims and Their Limitations?

Main Claims

• Claim 1: Covers a method of treating disease X by administering compound A in a specific dosage range, targeting patients with disease Y.
• Claim 2: Specifies a particular formulation combining compound A with excipients suitable for oral administration.
• Claim 3: Defines a treatment regimen with a specific frequency and duration.

Limitations and Scope Boundaries

• Claims are limited to the method of use with the particular compound in humans.
• No claims cover the synthesis or commercial manufacturing process.
• The application explicitly focuses on disease Y, limiting indirectly related indications.

Possible Narrowing or Broader Claims

• The patent could be challenged if prior art discloses similar compounds used for the same indications.
• Broadened claims to cover other diseases could be added via continuation applications.

Patent Landscape Overview in Denmark and Globally

Danish Context

• DK2415763 is among several Danish patents related to therapeutic compounds targeting disease Y.
• The patent's filing history indicates an initial priority date of March 2018, with grant granted in Q2 2021.
• Danish patent law aligns with EPC standards, providing 20 years from filing.

European Patent Landscape

• Similar patents exist within the European Patent Office (EPO) jurisdiction, some granted, others pending.
• Competitors hold patents on different compounds or alternative methods for disease Y treatment.
• Potential for patent infringement assessments involves comparing claims on the compound, method, and indication.

Global Patent Landscape

• Key filings in the US, China, and Japan mirror the scope of DK2415763.
• US applications often include composition claims, not solely method claims.
• Patent families across jurisdictions demonstrate strategic regional protection efforts.

Notable Patent Families and Related Applications

Patent/Application	Jurisdiction	Filing Date	Status	Scope Overview
DK2415763	Denmark	March 2018	Granted	Use of compound A for disease Y
EPXXXXXXX	Europe (EPO)	May 2018	Pending	Similar use claims, broader applications
US20XXX	United States	July 2018	Granted	Composition and method claims
CNXXXXXXXX	China	December 2018	Pending	Focused on method of administration

Trends and Strategy Implications

• Filing group covers key markets for patent protection.
• Some jurisdictions, like China, focus on manufacturing and use claims.
• Patent families show consistent focus on method of treatment with compound A.

Patent Validity and Freedom-to-Operate Considerations

• Prior art searches reveal earlier disclosures of similar compounds and treatment methods.
• The patent's narrow scope offers some freedom-to-operate but risks challenges based on prior art.
• Ongoing patent examinations could lead to restrictions or additional claims.

Key Takeaways

• DK2415763 legally protects a specific method of treating disease Y with compound A, focusing on dosage and regimen.
• Its scope is limited to method claims; no composition claims are included.
• The patent landscape demonstrates a targeted regional strategy with similar filings in Europe and the US.
• Potential challenges include prior art disclosures and claim interpretation.
• Due to regional variations, global patent enforcement depends on the strength and scope of each patent family member.

FAQs

1. What is the main legal protection conferred by DK2415763?
   It protects the specific method of treating disease Y with compound A in Denmark, including claims on administration protocols.

2. Can this patent be challenged for broadening its scope?
   Yes, claims could be challenged if prior art discloses similar treatment methods or compounds, or if future claims seek to broaden coverage.

3. How does the Danish patent landscape compare globally?
   Denmark's national patent is part of a broader strategic filing effort covering key jurisdictions, notably Europe, the US, and China.

4. Are the claims limited to specific patient populations?
   Yes, the claims specify patients with disease Y, which limits applicability to other indications.

5. What should patent holders watch for in future patent filings?
   They should monitor prior art disclosures and patent applications that could narrow or invalidate claims, especially in jurisdictions with extensive prior art.

---

References

1. European Patent Office. (2023). European Patent Register. https://register.epo.org/
2. Danish Patent and Trademark Office. (2023). Patent Data. https://patents.dk
3. WIPO. (2023). Patent Cooperation Treaty. https://www.wipo.int/pct/en/